Nanotechnology Now





Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Nanostart AG Publishes Figures for 2010 Fiscal Year

Abstract:
- Biggest profit in the company's history
- Expansion of Singapore business
- Increase of stakes in existing holdings

Nanostart AG Publishes Figures for 2010 Fiscal Year

Frankfurt am Main, Germany | Posted on June 1st, 2011

For the 2010 fiscal year, Frankfurt-based nanotechnology investment company Nanostart AG reports the biggest profit in its company history. Net income under German GAAP totaled €2.48 million, up 106 percent on the previous year (2009: €1.2 million). This means another successful year for Nanostart, which has been profitable from the beginning of operations.

Net income stemmed chiefly from the successful sale of shares in holdings, which raised around €4.4 million. In contrast to the previous year, costs were reduced, particularly for wages and salaries (2010: €-0.5 million, 2009: €-1 million). As a result of sound performance levels in the portfolio, the "write-downs on financial investments" item was halved from €-1.4 million in 2009 to €-0.7 million in 2010.

The shares of Nanostart Singapore Early Stage Venture Fund I in the Curiox Biosystems holding were sold in 2010. The transaction proceeds were plowed back into the fund and will be invested in new nanotechnology holdings in Singapore. Nanostart saw two further exits from its portfolio in 2010 with the sale of its shares in the two US holdings NanoGram and BioMicro Systems. The BioMicro transaction will be completed this year, generating further cash inflows for Nanostart in 2011.

Via Nanostart Singapore Early Stage Venture Fund I, a new equity investment was entered into at Singaporean company Microlight Sensors Pte Ltd in 2010. Founded in 2006, the company develops, produces and sells optical high-tech monitoring systems with extremely sensitive sensors. The fund holds around 19 percent of Microlight Sensors. In addition, Nanostart AG increased its stake in German Namos GmbH from 15 to 26 percent and the shareholding of the Singapore fund in Singaporean medical technology company BioMers Pte Ltd from 16 to around 25 percent.

A further equity investment has been entered into via the Singapore fund in the 2011 fiscal year. The new portfolio company is called Membrane Instruments and Technology Pte Ltd (MINT) and develops membrane-based sensors that monitor water quality in water treatment plants in real time. The fund holds 18 percent of MINT.

Nanostart will also be entering the Russian market in the current fiscal year. A €50 million fund is being created in conjunction with Russian company RUSNANO and the governor of Perm. It will invest in young nanotechnology companies in the Perm region and will be managed by Nanostart. Nanostart will receive a management fee of 3 percent p.a. on the fund volume for this. Across the entire fund term of 10 years, this equates to a cash inflow of up to €15 million. In addition, Nanostart AG will receive up to 25 percent of the fund's profits - equivalent to the economic value of an investment of €12.5 million - as well as the opportunity to invest up to €12.5 million in the fund itself.

For the current fiscal year, the expansion of the Nanostart portfolio is to be continued and the potential value of the existing portfolio is to be leveraged further.
The annual financial statements for 2010 are available on the Investor Relations section of the Nanostart website under "Company Reports". The 2010 annual report will be published on the company's website in the next few weeks.

####

About Nanostart AG
Nanostart AG (OTCQX: NASRY), headquartered in the German financial capital of Frankfurt, is the world’s leading nanotechnology investment company, with portfolio companies spanning the globe from Silicon Valley to Singapore. The company provides venture capital financing for nanotechnology companies in various growth phases with a focus on innovation-driven industries of the future such as cleantech, life sciences and IT/electronics. Through its subsidiary and venture capital fund in Singapore, Nanostart is proud to be the investment partner of the Singaporean government.

Disclaimer:

This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within Canada, Australia or Japan.

For more information, please click here

Contacts:
Nanostart AG
Head of Corporate Communications
Dr. Hans Joachim Dürr
Goethestrasse 26-28
D-60313 Frankfurt
Germany
phone: +49 (0)69-21 93 96 111
fax: +49 (0)69-21 93 96 150
e-mail:

Copyright © Nanostart AG

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

New technique speeds nanoMRI imaging: Multiplexing technique for nanoscale magnetic resonance imaging developed by researchers in Switzerland cuts normal scan time from two weeks to two days May 28th, 2015

Squeezed quantum cats May 28th, 2015

New chip makes testing for antibiotic-resistant bacteria faster, easier: Researchers at the University of Toronto design diagnostic chip to reduce testing time from days to one hour, allowing doctors to pick the right antibiotic the first time May 28th, 2015

Collaboration could lead to biodegradable computer chips May 28th, 2015

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

BESSTECH Announces $250K Investment from Eastern New York Angels : Funding will accelerate commercialization of BESSTECH’s innovative lithium-ion battery electrode technology and enable hiring of key personnel May 13th, 2015

Harris & Harris Group Portfolio Company OpGen Raises $17.1 Million in Initial Public Offering May 6th, 2015

Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015

Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015

Announcements

New technique speeds nanoMRI imaging: Multiplexing technique for nanoscale magnetic resonance imaging developed by researchers in Switzerland cuts normal scan time from two weeks to two days May 28th, 2015

Squeezed quantum cats May 28th, 2015

New chip makes testing for antibiotic-resistant bacteria faster, easier: Researchers at the University of Toronto design diagnostic chip to reduce testing time from days to one hour, allowing doctors to pick the right antibiotic the first time May 28th, 2015

Collaboration could lead to biodegradable computer chips May 28th, 2015

Financial Reports

PEN Inc. Announces First Quarter Financial Results: Investor Webcast and Business Update Set for May 21, 1 pm EDT May 13th, 2015

Arrowhead to Report Fiscal 2015 Second Quarter Financial Results May 4th, 2015

FEI Company: Strong Growth Prospects Remain May 1st, 2015

Harris & Harris Group Reports Financial Statements as of December 31, 2014 and Posts Annual Letter to Shareholders on Website March 17th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project